185 related articles for article (PubMed ID: 36670235)
41. Molecular regulation and function of FoxO3 in chronic kidney disease.
Lin F
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):439-445. PubMed ID: 32427691
[TBL] [Abstract][Full Text] [Related]
42. Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
[TBL] [Abstract][Full Text] [Related]
43. Effect of oral isotretinoin on the nucleo-cytoplasmic distribution of FoxO1 and FoxO3 proteins in sebaceous glands of patients with acne vulgaris.
Agamia NF; Hussein OM; Abdelmaksoud RE; Abdalla DM; Talaat IM; Zaki EI; El Tawdy A; Melnik BC
Exp Dermatol; 2018 Dec; 27(12):1344-1351. PubMed ID: 30240097
[TBL] [Abstract][Full Text] [Related]
44. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
45. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
[TBL] [Abstract][Full Text] [Related]
46. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
47. FOXO3 gene polymorphisms influence the risk of acute lymphoblastic leukemia in Chinese children.
Yang X; Wu X; Fang N; Liu X; Liu X; Yang L; Huang K; Luo A; Cai M; Wu F; Jiang H; Xu L
J Cell Biochem; 2020 Feb; 121(2):2019-2026. PubMed ID: 31691337
[TBL] [Abstract][Full Text] [Related]
48. FOXO1 represses lymphatic valve formation and maintenance via PRDM1.
Niimi K; Nakae J; Inagaki S; Furuyama T
Cell Rep; 2021 Nov; 37(9):110048. PubMed ID: 34852224
[TBL] [Abstract][Full Text] [Related]
49.
Montaño A; Ordoñez JL; Alonso-Pérez V; Hernández-Sánchez J; Santos S; González T; Benito R; García-Tuñón I; Hernández-Rivas JM
Cells; 2020 Jan; 9(1):. PubMed ID: 31952221
[TBL] [Abstract][Full Text] [Related]
50. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
51. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
[TBL] [Abstract][Full Text] [Related]
52. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.
Kibbe C; Chen J; Xu G; Jing G; Shalev A
J Biol Chem; 2013 Aug; 288(32):23194-202. PubMed ID: 23803610
[TBL] [Abstract][Full Text] [Related]
53. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
54. Gonadal expression of Foxo1, but not Foxo3, is conserved in diverse Mammalian species.
Tarnawa ED; Baker MD; Aloisio GM; Carr BR; Castrillon DH
Biol Reprod; 2013 Apr; 88(4):103. PubMed ID: 23486915
[TBL] [Abstract][Full Text] [Related]
55. FoxO transcription factors promote autophagy in cardiomyocytes.
Sengupta A; Molkentin JD; Yutzey KE
J Biol Chem; 2009 Oct; 284(41):28319-28331. PubMed ID: 19696026
[TBL] [Abstract][Full Text] [Related]
56. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
Bollinger LM; Witczak CA; Houmard JA; Brault JJ
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
[TBL] [Abstract][Full Text] [Related]
57. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Sharma G; Tran TM; Bansal I; Beg MS; Bhardwaj R; Bassi J; Tan Y; Jaiswal AK; Tso C; Jain A; Singh J; Chattopadhyay P; Singh A; Chopra A; Bakhshi S; Casero D; Rao DS; Palanichamy JK
J Exp Clin Cancer Res; 2023 Sep; 42(1):231. PubMed ID: 37670323
[TBL] [Abstract][Full Text] [Related]
58. Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle.
Lundell LS; Massart J; Altıntaş A; Krook A; Zierath JR
Mol Metab; 2019 Feb; 20():79-88. PubMed ID: 30502001
[TBL] [Abstract][Full Text] [Related]
59. Foxo1 is required in mouse spermatogonial stem cells for their maintenance and the initiation of spermatogenesis.
Goertz MJ; Wu Z; Gallardo TD; Hamra FK; Castrillon DH
J Clin Invest; 2011 Sep; 121(9):3456-66. PubMed ID: 21865646
[TBL] [Abstract][Full Text] [Related]
60. FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.
Czymai T; Viemann D; Sticht C; Molema G; Goebeler M; Schmidt M
J Biol Chem; 2010 Apr; 285(14):10163-78. PubMed ID: 20123982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
